1. Home
  2. EVO vs ALX Comparison

EVO vs ALX Comparison

Compare EVO & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • ALX
  • Stock Information
  • Founded
  • EVO 1993
  • ALX 1928
  • Country
  • EVO Germany
  • ALX United States
  • Employees
  • EVO N/A
  • ALX N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • ALX Real Estate Investment Trusts
  • Sector
  • EVO Health Care
  • ALX Real Estate
  • Exchange
  • EVO Nasdaq
  • ALX Nasdaq
  • Market Cap
  • EVO 1.4B
  • ALX 1.2B
  • IPO Year
  • EVO 2021
  • ALX N/A
  • Fundamental
  • Price
  • EVO $3.31
  • ALX $229.75
  • Analyst Decision
  • EVO Strong Buy
  • ALX
  • Analyst Count
  • EVO 1
  • ALX 0
  • Target Price
  • EVO $7.00
  • ALX N/A
  • AVG Volume (30 Days)
  • EVO 54.5K
  • ALX 81.2K
  • Earning Date
  • EVO 11-05-2025
  • ALX 11-03-2025
  • Dividend Yield
  • EVO N/A
  • ALX 7.89%
  • EPS Growth
  • EVO N/A
  • ALX N/A
  • EPS
  • EVO N/A
  • ALX 7.14
  • Revenue
  • EVO $887,396,457.00
  • ALX $215,838,000.00
  • Revenue This Year
  • EVO N/A
  • ALX N/A
  • Revenue Next Year
  • EVO $10.78
  • ALX N/A
  • P/E Ratio
  • EVO N/A
  • ALX $32.62
  • Revenue Growth
  • EVO N/A
  • ALX N/A
  • 52 Week Low
  • EVO $2.84
  • ALX $184.76
  • 52 Week High
  • EVO $5.64
  • ALX $260.84
  • Technical
  • Relative Strength Index (RSI)
  • EVO 28.61
  • ALX 48.50
  • Support Level
  • EVO $3.30
  • ALX $213.44
  • Resistance Level
  • EVO $4.09
  • ALX $240.00
  • Average True Range (ATR)
  • EVO 0.09
  • ALX 7.85
  • MACD
  • EVO -0.08
  • ALX -0.04
  • Stochastic Oscillator
  • EVO 2.06
  • ALX 61.41

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ALX Alexander's Inc.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.

Share on Social Networks: